Aurora Cannabis (ACB) vs Aquestive Therapeutics (AQST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aquestive Therapeutics (AQST) has outperformed Aurora Cannabis (ACB) over the past year, losing 23.2% versus a loss of 27.4%. Over five years, AQST leads with a +23.0% price change compared with -93.7% for ACB. Aquestive Therapeutics is the larger company by market cap ($597.4 million vs $280.5 million), about 2.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | AQST |
|---|---|---|
| Share price | $4.43 | $4.76 |
| Market cap | $280.46M | $597.44M |
| 1-day change | -0.67% | +3.03% |
| YTD return | +4.98% | -26.32% |
| 1-year return | -27.38% | -23.23% |
| 5-year return | -93.70% | +23.00% |
| EPS (TTM) | $-0.61 | $-0.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $7.55 |
| 52-week low | $2.56 | $2.93 |
| Distance from 52-week high | -33.53% | -36.95% |
| Analyst consensus | buy | none |
| Avg. price target upside | — | +96.01% |
| Average volume | 1.36M | 2.68M |
| Shares outstanding | 63.31M | 125.51M |
| Employees | 1,028 | 147 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aquestive Therapeutics is about 2.1 times larger than Aurora Cannabis by market value ($597.44M vs $280.46M).
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Aquestive Therapeutics
AQST stock →Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 147 employees
ACB vs AQST FAQ
Which is bigger, Aurora Cannabis or Aquestive Therapeutics?
Aquestive Therapeutics (AQST) is larger, with a market capitalization of $597.44M compared with $280.46M for Aurora Cannabis (ACB).
Which stock has performed better over the past year, ACB or AQST?
AQST returned -23.23% over the past 12 months, compared with -27.38% for ACB (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Aquestive Therapeutics in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.